# Correction: Chidamide combined with doxorubicin induced p53-driven cell cycle arrest and cell apoptosis reverse multidrug resistance of breast cancer

**Authors:** Lixia Cao, Shaorong Zhao, Qianxi Yang, Zhendong Shi, Jingjing Liu, Teng Pan, Dongdong Zhou, Jin Zhang

PMC · DOI: 10.3389/fonc.2025.1722174 · Frontiers in Oncology · 2026-01-12

## Full-text entities

- **Genes:** TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}
- **Diseases:** breast cancer (MESH:D001943)
- **Chemicals:** doxorubicin (MESH:D004317), Chidamide (MESH:C547816)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12833620/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12833620/full.md

---
Source: https://tomesphere.com/paper/PMC12833620